Deepak Srivastava, M.D., is a nonresident scholar for biomedical research policy. President of the Gladstone Institutes, he is also a senior investigator, and director of Gladstone’s Roddenberry Stem Cell Center. He is a professor of pediatrics and of biochemistry and biophysics at the University of California, San Francisco (UCSF) and holds the Robert W. and Linda Mahley Distinguished Professorship. Srivastava’s laboratory used genetics to demonstrate that a decrease in dosage of some cardiac developmental regulators can cause cardiac septal defects and valve disease, and is now using induced pluripotent stem cells to discover the mechanisms of disease. His team reprogrammed nonmuscle cells in a mouse heart to function like heart muscle cells, effectively regenerating heart muscle after damage. Additionally, Srivastava co-founded a biotechnology company to help find new cures for human diseases. Before joining Gladstone, Srivastava was a professor in the Department of Pediatrics and Molecular Biology at The University of Texas Southwestern (UTSW) Medical Center in Dallas. He has been named an endowed chair at both UTSW and UCSF, and has been elected to the American Society for Clinical Investigation, the American Academy of Arts and Sciences, and the American Association for the Advancement of Science. Srivastava completed his undergraduate degree at Rice University, medical training at The University of Texas Medical Branch in Galveston and his residency in the Department of Pediatrics at UCSF. He also did a fellowship in pediatric cardiology at the Children’s Hospital of Harvard Medical School and a postdoctoral fellowship at the MD Anderson Cancer Center.

Contact at [email protected] or 415-734-2716.